FOXO4-DRI (10mg)
FOXO4-DRI is an investigational peptide designed to selectively target senescent cells, which contribute to aging and tissue decline. By disrupting FOXO4-p53 interactions, it may encourage the clearance of damaged cells and restore tissue function. It is positioned as an advanced candidate in longevity and anti-aging science.
Product Highlights
Dosing Instructions
Administer subcutaneously per investigational protocol. Utilize defined cycles with monitoring for tolerance and functional outcomes.
Compound Information
Primary Use: Senolytic support for longevity programs.
Class: Cell-penetrating peptide inhibitor (FOXO4–p53 interaction).
Molecular Weight: Peptide; product-dependent.
Formula: Peptide.
Mechanism: Disrupts survival signaling in senescent cells to promote their clearance (investigational).
Administration: Subcutaneous.
Half-Life: Not well established; protocol-driven.
Note: All peptide products are for research purposes only. Information provided is educational and not a substitute for medical advice.
Need help with mixing your peptides? Use our peptide mixing calculator below.
Description
Additional information
| Weight | 6 g |
|---|---|
| Dimensions | 3.7 × 1.5 × 1.5 in |

